Wenyi Q. Gu

Corner College And Cooper Roads
Brisbane, QLD 4072, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 182 publications

Mechanisms of Gut Microbiota-Derived Metabolites in Treating Hyperuricemia: Natural Products as Interventions.

Mechanisms of Gut Microbiota-Derived Metabolites in Treating Hyperuricemia: Natural Products as Interventions.

Journal: Molecules (Basel, Switzerland)

Published: June 03, 2026

Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocol.

Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocol.

Journal: BMJ open

Published: May 18, 2026

HBV re-activation is associated with increased mortality and dysregulation of oxidative and polyamine metabolism in pre-acute-on-chronic liver failure.

HBV re-activation is associated with increased mortality and dysregulation of oxidative and polyamine metabolism in pre-acute-on-chronic liver failure.

Journal: Cell communication and signaling : CCS

Published: April 27, 2026

Short-term mortality is reduced and low grade ACLF reversed by TIPS in patients with fluid overload: a case-control study.

Short-term mortality is reduced and low grade ACLF reversed by TIPS in patients with fluid overload: a case-control study.

Journal: Clinical and translational gastroenterology

Published: February 13, 2026

Conversion to LCP Tacrolimus Mitigates Calcineurin-Induced Nephrotoxicity in Patients After Liver Transplantation.

Conversion to LCP Tacrolimus Mitigates Calcineurin-Induced Nephrotoxicity in Patients After Liver Transplantation.

Journal: Clinical transplantation

Published: February 12, 2026

Effect of evolocumab on the gut microbiota in patients with acute myocardial infarction.

Effect of evolocumab on the gut microbiota in patients with acute myocardial infarction.

Journal: Journal of medical microbiology

Published: January 13, 2026

Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults

Position paper for the standardized use of transjugular intrahepatic portosystemic shunt (TIPS) in adults

Journal: Zeitschrift fur Gastroenterologie

Published: November 10, 2025

Evaluation of changes in serum measles antibody levels in children with tumors before and after chemotherapy and the necessity of revaccination with measles-containing vaccines

Evaluation of changes in serum measles antibody levels in children with tumors before and after chemotherapy and the necessity of revaccination with measles-containing vaccines

Journal: Zhonghua yi xue za zhi

Published: September 04, 2025

High-grade uterine endometrial stromal sarcoma harboring GLI1 and MDM2/CDK4 co-amplifications.

High-grade uterine endometrial stromal sarcoma harboring GLI1 and MDM2/CDK4 co-amplifications.

Journal: Diagnostic pathology

Published: July 28, 2025

The burden of extrahepatic organ failures in European patients with cirrhosis.

The burden of extrahepatic organ failures in European patients with cirrhosis.

Journal: Hepatology communications

Published: June 23, 2025

Validation of the CLIF-SIG score in patients with HBV-related acutely decompensated cirrhosis.

Validation of the CLIF-SIG score in patients with HBV-related acutely decompensated cirrhosis.

Journal: Gut

Published: May 06, 2025

Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose study.

Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose study.

Journal: The lancet. Gastroenterology & hepatology

Published: April 08, 2025

Showing 1-12 of 182

Last Updated: 09/26/2026